Neuropathic pain is a debilitating consequence of neuronal injury or disease. Although first line treatments include the alpha-2-delta (a2d)-ligands, pregabalin and gabapentin (GBP), the mechanism of their anti-allodynic action is poorly understood. One specific paradox is that GBP relieves signs of neuropathic pain in animal models within 30min of an intraperitoneal (IP) injection yet its actions in vitro on spinal dorsal horn or primary afferent neurons take hours to develop. We found, using confocal Ca 2þ imaging, that substantia gelatinosa neurons obtained ex vivo from rats subjected to sciatic chronic constriction injury (CCI) were more excitable than controls. We confirmed that GBP (100 mg/kg) attenuated mechanical allodynia in animals subject to CCI within 30min of IP injection.Substantia gelatinosa neurons obtained ex vivo from these animals no longer displayed CCI-induced increased excitability. Electrophysiological analysis of substantia gelatinosa neurons ex vivo suggest that rapidly developing in vivo anti-allodynic effects of GBP i) are mediated intracellularly, ii) involve actions on the neurotransmitter release machinery and iii) depend on decreased excitatory synaptic drive to excitatory neurons without major actions on inhibitory neurons or on intrinsic neuronal excitability. Experiments using in vivo Ca 2þ imaging showed that 100 mg/kg GBP also suppressed the response of the S1 somatosensory cortex of CCI rats, but not that of control rats, to vibrotactile stimulation.
a b s t r a c t
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Introduction
Injury to the somatosensory system can produce 'neuropathic' pain that lasts for months or years after any injury has healed (Treede et al., 2008; Costigan et al., 2009; Berger et al., 2011) . This maladaptive 'disease of pain' has a 1.5e3% prevalence within the general population (Torrance et al., 2006) and can associate with diabetic, postherpetic or HIV-related neuropathies, with multiple sclerosis or fibromyalgia as well as with traumatic nerve, spinal cord or brain injury (including stroke). It is associated with marked disruption of sensory signaling at the peripheral, spinal, thalamic and cortical levels (Sandkuhler, 2009; Zhuo, 2008; Patel and Dickenson, 2016; Chen et al., 2014a; Pitcher and Henry, 2008) .
Afflicted individuals exhibit hyperalgesia, allodynia (the generation of a painful sensation by an innocuous stimulus) and bouts of stimulus-independent "electric shock like" pain (Mogil, 2009) . Some experience causalgia (a persistent, burning pain).
Unfortunately, neuropathic pain is poorly responsive to opioid analgesics and this can lead to over-prescription and abuse. Even the "a2d ligands", pregabalin (PGB) and gabapentin (GBP), which are first line treatments (Finnerup et al., 2015) are not universally effective and as many as 65% of patients fail to report appreciable pain relief (Moore et al., 2014) . To better understand the mechanism of gabapentinoid action, we have addressed a paradox relating to their time course of action. Accepted animal models of neuropathic pain include experimental lesion of peripheral nerves such as sciatic chronic constriction (CCI) (Kim et al., 1997; Mosconi and Kruger, 1996) or spared nerve injury (SNI) (Decosterd and Woolf, 2000) . In such models, gabapentinoids attenuate hyperalgesia and/or allodynia within 30e60min of a parenteral injection (Hunter et al., 1997; Kayser and Christensen, 2000; Field et al., 2006; Kumar et al., 2013; Alles and Smith, 2016; Luo et al., 2002) . Despite this, their reported actions on nociceptive neurons in spinal cord or dorsal root ganglia (DRG) in vitro are 10e30 times slower; taking 10e15 h to develop (Hendrich et al., 2008; Hendrich et al., 2012; Biggs et al., 2014) .
Alpha-2-delta (a2d) refers to a family of accessory subunits that co-assemble with the pore forming a-subunits of high voltagegated (HVA) Ca 2þ channels (Dolphin, , 2013 Zamponi et al., 2015; Dolphin, 2016) . One such subunit, a2d-1 is upregulated in the DRG of animals subject to peripheral nerve injury and this coincides with the onset of signs of neuropathic pain (Luo et al., 2001; Luo et al., 2002; Bauer et al., 2009) . Pain behaviors also appear in animals genetically engineered to overexpress a2d-1 (Li et al., 2006; Li et al., 2004) . Gabapentinoids are transported into the neuronal cytoplasm, where they bind to a2d-1 subunits (Gee et al., 1996; Field et al., 2006; Lana et al., 2016; Field et al., 2006; Hendrich et al., 2008; Lana et al., 2016) . This interaction interferes with both the trafficking of a2dÀ1 between the DRG cell body and primary afferent terminal (Bauer et al., 2009 ) and the local trafficking of a2d-1 subunits and their associated, pore forming a-subunits between the endoplasmic reticulum and the cell surface (Hendrich et al., 2008) . Within nerve terminals, this impedes the ability of HVA-Ca 2þ channels to interact with the vesicle fusion machinery for neurotransmitter release (Hoppa et al., 2012) . This leads to attenuation of synaptic transmission between nociceptive primary afferents and second order sensory neurons in the spinal dorsal horn (Hendrich et al., 2012; Biggs et al., 2014) . It has been suggested that gabapentinoids antagonize the actions of the novel neurotrophin, thromospondin 4 which also binds a2d (Pan et al., 2016; Lana et al., 2016) . Studies that failed to observe a rapidly developing, acute action of GBP in vitro (Moore et al., 2002; Biggs et al., 2014; Hendrich et al., 2008) were done on dorsal horn neurons from naive animals rather than those subject to nerve injury. To the best of our knowledge, there are no studies of the acute antiallodynic action of gabapentinoids in the chronic constriction injury (CCI) or spared nerve injury (SNI) model of neuropathic pain (Mosconi and Kruger, 1996; Decosterd and Woolf, 2000) that are correlated with changes in dorsal horn neurons. Furthermore, no attempts have been made to correlate the rapidly developing in vivo actions of GBP with acute changes in sensory processing at the level of the spinal cord or cortex.
We find, by studying neurons obtained ex vivo from animals that are responding to GBP, that the rapid time course of its in vivo antiallodynic effect coincides temporally with altered synaptic transmission within the dorsal horn. Further analysis of rapidly developing GBP actions in substantia gelatinosa ex vivo suggest that i) they are mediated via an intracellular interaction, ii) they involve actions on the neurotransmitter release machinery iii) they involve differential effects on excitatory and inhibitory neurons.
It is possible that the GBP-induced increase in paw withdrawal threshold in nerve damaged animals (Hunter et al., 1997; Kayser and Christensen, 2000; Field et al., 2006; Kumar et al., 2013; Alles and Smith, 2016; Luo et al., 2002 ) is a simple reflection of attenuation of spinal withdrawal reflexes rather than the attenuation of pain per se. We therefore examined whether an acute behavioral drug response could be correlated with alterations in the response of the somatosensory cortex (S1) to vibrotactile stimulation (Potter et al., 2016) . S1 is a component of the "pain matrix" (Legrain et al., 2011; Eto et al., 2011) . It is involved in processing sensorydiscriminative aspects of both painful and non-painful touch (Komagata et al., 2011) . Structural changes in S1 neurons have been reported to correlate with chronic neuropathic pain states (Kim et al., 2012) . We found that vibrotactile stimulation of the limb ipsilateral to sciatic CCI produced robust S1 activation that was attenuated by the acute administration of GBP. A preliminary report of some of these findings has appeared (Alles et al., 2015) .
Materials and methods
All animal experiments were approved by the University of Alberta Health Sciences Animal Welfare committee in accordance of the guidelines of the Canadian Council on Animal Care.
Surgery-Chronic Constriction Injury (CCI)
Fifty six male Sprague Dawley rats (21-23d) were subject to 7-10d chronic constriction injury (CCI) of the sciatic nerve (Mosconi and Kruger, 1996) as described previously (Balasubramanyan et al., 2006) . Briefly, the left sciatic nerve of rats under isoflurane anesthesia (5% induction, 2% maintenance) was exposed at midthigh level and two PE 90 polyethylene cuffs (ID 0.86 mm, OD 1.27 mm) were slit open on one side and gently attached around the sciatic nerve. The wound was closed with a silk suture, In the case of sham surgery, Forty six male rats (21-23d) were anesthetized under isoflurane and the sciatic nerve was exposed, but not touched with the forceps.
Surgery -Spared Nerve Injury (SNI)
Following isoflurane anesthesia as described above, eight male Sprague Dawley rats were subject to spared nerve injury (SNI) (Decosterd and Woolf, 2000; Pertin et al., 2012 ). An incision was made through the biceps femoris to expose the sciatic nerve and the three terminal branches: the sural, common peroneal, and tibial The SNI procedure involved the ligation and transection of the common peroneal and tibial nerve, while leaving the third sural nerve intact.
Both the common peroneal and tibial nerves were tightly ligated with 5.0 silk and sectioned.
Approximately 5 mm distal to the ligation A 2e4 mm segment was removed from the distal portion of the nerve stumps using care to avoid making unwanted contact with the sural nerve. Finally, the muscle and skin were closed in two layers, using sutures and wound clips, respectively.
Behavioral testing
Male Sprague-Dawley rats were tested for mechanical allodynia and hyperalgesia at 7e12 days after surgery (Fig. 1a) using von Frey filaments of 1.4 g, 2 g, 4 g, 6 g, 10 g and 15 g weights. Animals were tested prior to and 30min after injection of 100 mg/kg GBP or saline (Fig. 1a) . This dose is submaximal for the relief of inflammatory pain (Field et al., 1997) and corresponds to the 90 mg/kg dose which blocks ectopic nerve injury in nerve injured rats without effect on nerves from uninjured animals (Pan et al., 1999) . For testing, animals were placed in a plexiglass box with a wire-grid bottom and pressure was applied to the mid-plantar area of the left paw (injured side) starting with a von Frey filament of the lowest weight (1.4 g) until it bent and then was held in this position for 2 s. This was performed 5 times and a positive result for each hair would be given if the animal withdrew its paw a minimum of 3 out of 5 times. If a negative result was obtained, the next heaviest filament would be used. A recovery period of at least 1 min between was allowed between successive filament applications. The paw withdrawal threshold (PWT) was calculated based on the weight of von Frey filament that elicited a positive result. Rats with a paw withdrawal threshold of 6 g or less were considered to be exhibiting mechanical allodynia (Balasubramanyan et al., 2006) .
Preparation of acute spinal cord slices
7-12 d after CCI or sham-surgery, animals were tested behaviourally for the presence of allodynia. Those exhibiting a PWT <6 g received an IP injection of 100 mg/kg GBP or control injection of saline. Following behavioural confirmation of an antiallodynic effect of GBP, animals were anesthetized with a large overdose of intra-peritoneal urethane (1.5 g/kg). Because animals developed allodynia at different rates and experiments were done on 6 animals per batch, it was possible to stagger electrophysiological analysis over a 5-6d period. This meant the youngest animals tested were 28d old (surgery at 21d, 7d to develop allodynia, tested immediately) and oldest were 40d (surgery at 23d, 12d to develop allodynia, tested 5d later).
Following anesthesia and the cessation of cardiac contraction and loss of ocular reflexes, the spinal cord was removed via laminectomy and transferred to partly-frozen, 'slushy' artificial cerebrospinal fluid (aCSF) containing (in mM): 118 NaCl, 2.5 KCl, 26 NaHCO 3 , 1.3 MgSO 4 , 1.2 NaH 2 PO 4 , 1.5 CaCl 2 , 5 MgCl 2 , and 25 Dglucose, 1 kynurenic acid. This solution was continuously bubbled with carbogen (95% O 2 , 5% CO 2 ). The L4-L7 region of the cord was glued with cyanoacrylate glue to a trapezoid-shaped block made out of 4% agar. Transverse slices (300 mm) were cut using a Microm HM 650 V vibratome (Thermo Scientific, Waltham, MA, USA). Slices were incubated in~200mls aCSF (without kynurenic acid) at 37 C for 1 h prior to recording and then stored at room temperature (22e24 C) for the remainder of the experimental day (Moran et al., 2004) . Slices were thus examined between approximately 200 and 360min following euthanasia (Fig. 1a) . Recordings were made from the substantia gelatinosa, which was identified by its translucent appearance under IR-DIC (infrared-differential interference) optics and were made from the side ipsilateral to the sciatic injury. The side ipsilateral to the nerve injury was marked by cutting a longer piece of agar along the desired side of the spinal cord after slicing was complete.
Calcium imaging of acutely isolated spinal cord slices
During calcium imaging, slices were perfused at room temperature (22e24 C) with 95% O 2 e5% CO 2 saturated aCSF containing (in mM): 127 NaCl, 2.5 KCl, 1.2 NaH 2 PO 4 , 26 NaHCO 3 , 1.3 MgSO 4 , 2.5 CaCl 2 and 25 D-glucose, pH 7.4. Acute spinal cord slices were imaged using a scanning confocal microscope (Olympus FV300) connected to an Argon laser (488 nm) for confocal (single-photon) imaging using a 20 Â objective (Olympus NA 1.0) and 2e3 Â optical zoom at full-frame (512 Â 512 pixels). Neurons were visualized using the membrane- A one-way analysis of variance (ANOVA) with Bonferroni correction was used to calculate differences in (F max e F 0 )/F 0 between CCI and sham-operated animals that had received either GBP or saline.
In vivo two-photon cortical imaging
This technique employs pressure injection of Ca 2þ -indicator dyes directly into the somatosensory cortex of anesthetized rats to measure rises in intracellular Ca 2þ of individual neurons in response to vibrotactile stimulation of the hind limb (Winship and Murphy, 2008) . CCI or sham-operated rats (30e40 days old) were affixed to a stereotaxic frame. A surgical plane of anesthesia was achieved with 20% (w/v) urethane dissolved in saline and administered via intraperitoneal injection (1.25 g/kg; supplemented at 0.25 g/kg as needed). Body temperature was measured using a rectal probe and maintained at 37 ± 0.5 C. An incision was made along the medial portion of the scalp and the skin retracted to expose the skull. Bleeding from the scalp was electro-cauterized to prevent leaking onto the exposed surface of the skull. A 4 Â 4 mm region of the skull overlying the right hemisphere somatosensory region was thinned to 25e50% of original thickness using a highspeed dental drill (~1.5e4.5 mm lateral, þ1.5 to À2.5 mm posterior to bregma). This thinned region was covered with 1.3% lowmelt agarose dissolved in aCSF at 37 C containing in mM: NaCl 135, KCl 5.4, MgCl 2 $6H 2 O 1, CaCl 2 $2H 2 O 1.8, NaHEPES 5. The region was then covered with a 5 mm glass coverslip. Hemodynamic intrinsic optical signal (IOS) imaging was performed through this thin skull preparation before in vivo Ca 2þ imaging (Winship and Murphy, 2008) . Imaging of intrinsic optical signals and local changes in blood flow using two-photon imaging have shown that blood flow to active areas of the cerebral cortex increases within 600 ms of the onset of neuronal activity (Winship et al., 2007) . For IOS imaging, the cortical surface was illuminated with a red LED (635 nm). Reflected light was captured in 12-bit format by a Dalsa Pantera 1M60 camera mounted on a Leica SP5 confocal microscope.
The depth of focus was set between 200 and 300 mm below the cortical surface. Custom-made piezo-electric mechanical bending actuators were used to elicit vibrotactile limb stimulation (1s, 200 Hz) during IOS imaging (Winship and Murphy, 2008) . A total of 40 trials of stimulation was performed on the hindlimb contralateral (cHL) to the cortex imaged and corresponding to the nerve-injured side. Placement of actuators was on the glabrous skin of the cHL, with consistent alignment relative to the flexion of wrist and ankle. Images were captured for 3.0 s at 10 Hz (0.5s before and 2.5s after stimulus onset; inter-stimulus interval ¼ 20s). The 40 trials were averaged in ImageJ software (NIH). Frames 1e1.5s after stimulus onset were averaged and divided by baseline frames 0.5s before stimulus onset to generate a hindlimb response map. The response map threshold was set at 50% maximal response, and overlaid on an image of surface vasculature to delineate the cHL somatosensory area (Fig. 1bef ). These areas were subsequently used as guides for Ca 2þ indicator injections (Winship and Murphy, 2008) .
Subsequent to IOS imaging, the coverslip and agarose were removed. A metal plate was secured to the skull using cyanoacrylate glue and dental cement and then fastened to the surgical stage to prevent head movement. A 3 Â 6 mm craniotomy was then performed centering over the cHL functional area, determined via IOS imaging. A dental drill was used to progressively thin the overlying skull until the bone could be removed with forceps, and the dura resected. The exposed cortical surface was bathed in saline. Pressure injections of membrane-permeant Oregon Green BAPTA-1 (OGB-1) were made 200e300 mm below the cortical surface of the HL cortical region using glass micropipettes with resistances of 2e5 MU (Stosiek et al., 2003; Winship and Murphy, 2008) . Alexa-594 was used as a tracer alongside OGB-1 to determine whether dye was being successfully ejected from the micropipette tip. Multiple injections were performed until a desired level of loading was achieved. Typical loading is shown in Fig. 1b . After OGB-1 injection, the cortex was incubated for 10 min with sulforhodamine 101 (SR101) dissolved in DMSO to label astrocytes (Winship and Murphy, 2008; Winship et al., 2007) . The craniotomy was then covered with 1.3% agarose dissolved in aCSF and sealed with a glass coverslip. Two-photon imaging was performed using a Leica SP5 MP confocal microscope equipped with a titanium-sapphire laser tuned to 810 nm for OGB-1 and SR101 excitation. A Leica HCX PL APO L 20 Â 1.0NA water immersion objective was used. Images were acquired using Leica LAS AF using two line-averages, a zoom of 1.7Â and a frame-rate of 25 Hz. Images were acquired at 256 Â 256 pixels over an area of 434 Â 434 mm, yielding a resolution of 1.7 mm per pixel. Ca 2þ fluctuations in neurons and astrocytes were imaged at 130-180mm below the cortical surface.
Using custom scripts written in NIH ImageJ, a median filter (radius, 1 pixel) was applied to each of the image sequences of 8 trial sweeps. The 8 filtered trails were then averaged to generate the final Ca 2þ imaging frames to be analyzed. Regions of interest (ROIs) were drawn around visible neurons. Astrocytes were excluded from analysis by removing ROIs that co-labelled astrocytes in the SR101 channel. Numerical values representing raw neuronal fluorescence traces were exported from ImageJ and were imported into Microsoft Excel. A 5-point moving triangular smoothing filter was applied to each neuronal trace to increase signal-to-noise ratio. We found that this triangular filter did not affect the overall amplitude or main signal properties of our recorded Ca 2þ traces, but did reduce single frame Ca 2þ trace artifacts. DF/Fo traces were generated from the raw fluorescence traces as previously described and with Alexa-594 (tracer) following injection into the cortex up to a depth of 300 mm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) (Winship and Murphy, 2008) . Neuronal Ca 2þ signals were exported from Microsoft Excel and analyzed in Clampfit 9.0 (Molecular Devices, Silicon Valley, CA, USA). Due to the large number of signal traces that required analysis, various threshold criteria were tested to differentiate responsive from un-responsive neurons (Winship and Murphy, 2008) . A threshold criterion requiring the neuronal Ca 2þ fluorescence to increase by 3-times the standard deviation of the baseline period (baseline defined as 1s before stimulus onset), and remain above this criteria for 160 ms (4 successive frames), was found to be optimal for separating responsive neurons from noise (Fig. 1d) . Neuronal traces that met these criteria were included in subsequent analysis. The index of excitability used for cortical excitability was the 'neural mass' or the fraction of responsive cells multiplied by the mean normalized response (Doetsch, 2000) . This measure provided a more suitable parameter for comparing neuronal population coding and excitability of the PSC between different animals.
A one-way analysis of variance (ANOVA) with Bonferonni correction was used for comparing the neural mass between animals. Statistical significance was attributed if p < 0.05.
Measurement of GBP levels
21-30 day old Sprague-Dawley rats received either saline, 60 mg/kg GBP or 100 mg/kg GBP via intraperitoneal injection. After approximately 30 min, animals were anesthetized with a large overdose of intra-peritoneal urethane (1.5 g/kg) and spinal cords removed via laminectomy as described above. Whole brain was removed by making an incision along the midline of the head, peeling back the skin, cutting open the skull and dissecting out the brain.
Whole spinal cord or brain were frozen on solid CO 2 and stored in isopentane at À80 C. Individual 300 mm transverse spinal cord slices were prepared as described above from rats that had received 100 mg/kg IP GBP 30min prior to euthanasia. They were subjected to the full protocol slice preparation for electrophysiology (Fig. 1a) prior to freezing on solid CO 2 and storage in isopentane for subsequent GBP measurement. All measurements were thus made from slices frozen approximately 155min following in vivo drug injection (Fig. 1a) .
At the time of analysis, samples were homogenized in ice cold methanol. For a standard control, 100 ml of the homogenate from saline-injected animal brain or spinal cord homogenate was used and for comparison, 100 ml of homogenate from GBP-injected animal brain or spinal cord homogenate was used in analysis. Samples were vortexed, placed on ice for 10 min and centrifuged at 10,000g for 4 min. A calibration curve consisting of varying amounts of authentic GBP added to drug-free naive homogenates was run in parallel with each run. The supernatant was transferred to a low volume silanized glass insert and 20 ml of supernatant was injected onto the LCMS. Analysis was performed using a Waters ZQ Mass detector fitted with an ESCI Multi-Mode ionization source and coupled to a Waters 2695 Separations module (Waters, Milford, MA, USA). Mass Lynx 4.0 software was used for instrument control, data acquisition and processing. HPLC separation was performed on an Atlantis dC18 (3 mm, 3.0 Â 100 mm) column (Waters, Milford, MA, USA) with a guard column of similar material. Mobile phase A consisted of 0.05% formic acid in water and mobile phase B was composed of 0.05% formic acid in acetonitrile. Initial conditions were 80% A and 20% B at a flow rate of 0.3 ml/min. A gradient was run increasing to 80% B in 15 min followed by a return to initial conditions. The column heater and sample cooler were held at 30 C and 4 C respectively. Optimized positive electrospray parameters were as follows: capillary voltage 3.4 kV; Rf lens voltage 1.0 V; source 110 C; desolvation temperature 350 C; cone gas flow (nitrogen) 100L/Hr; desolvation gas flow (nitrogen) 500 L/Hr. Cone voltage was held at 20 V. Acquisition was done in the Single Ion Monitoring (SIM) mode and the mass:charge ratio was set at 171.2 to correspond to the molecular weight of GBP.
Electrophysiology
Acutely isolated spinal cord slices were superfused at room temperature (22e24 C) with 95% O 2 e 5% CO 2 saturated aCSF. The substantia gelatinosae were visualized under IR-DIC (infrared-differential interference) optics as a translucent band. Pipettes for recording had a resistance of 6e8 MU when filled with an internal solution that contained (in mM): 130 potassium gluconate, 1 MgCl 2 , 2 CaCl 2 , 10 HEPES, 10 EGTA, 4 Mg-ATP and 0.3 Na-GTP, pH 7.18e7.20, 290e300 mOsm.
An NPI SEC-05LX amplifier was used for recording in discontinuous, single electrode, current or voltage-clamp mode. Only data from neurons that produced a clear action potential overshoot of greater than 60 mV in amplitude were collected and data were collected from just one neuron per slice. Neurons were characterized on the basis of firing pattern in response to 800 ms depolarizing current pulses from a holding potential of À60 mV according to criteria in Balasubramanyan et al. (2006) as either tonic, delay, phasic, transient or irregular. For measurement of excitability, current ramp commands were applied and discharge rates were analyzed as cumulative latency plots (Stemkowski and Smith, 2012) . Current ramps were delivered at 33, 67, 100 or 133 pAs À1 .
Only the 133 pAs
À1 was used in analysis as this provided more discharge pattern data for comparison between cell types. Spontaneous excitatory post-synaptic currents (sEPSCs), were recorded at À70 mV. Miniature excitatory post-synaptic currents (mEPSCs), were recorded in the same way but in the presence of 1 mM TTX. All sEPSC and mEPSC were examined and visually accepted or rejected based on visual examination. Acceptable events had a sharp onset and exponential offset, a total duration of <50 ms and an amplitude at least double the baseline noise. 3 min recordings were analyzed from each neuron.
Drugs and chemicals
TTX was from Alomone Laboratories, Jerusalem, Israel. Kynurenic acid (Tocris) was from Cedarlane Laboratories (Hornby, Ontario, Canada). Gabapentin was from TTCI America, (Portland, Oregon, USA). Fluo-4 AM cell permeant, Oregon Green 488 Bapta-1 and sulforhodamine (SR-101) werefrom Molecular Probes, Invitrogen, Carlsbad, CA, USA. All other drugs and chemicals were from Sigma, St. Louis, MO, USA.
Data analysis software
All data and statistical analysis was performed using Origin 2015 (Origin Lab Corp., Northampton, MA, USA, www.originlab.com), except analysis of sEPSCs and mEPSCs which was performed using MiniAnalysis (Synaptosoft, Decatur, GA, USA, www.synaptosoft. com) and analysis of current ramp data which was performed using pCLAMP 8.0 (Molecular Devices Sunnyvale, CA, USA).
Results

A single IP injection of GBP increases paw withdrawal threshold in neuropathic rats within 30 min
We have shown previously that a single intraperitoneal injection of 100 mg/kg GBP in neuropathic CCI rats significantly increases the PWT within 30 min (Alles and Smith, 2016) . In confirmation of this, Fig. 2a illustrates the increase in withdrawal threshold in rats subject to CCI 30min after IP injection of 100 mg/ kg GBP (n ¼ 23) but not after injection of saline. Sham operated rats exhibited a withdrawal threshold of 15.0 ± 0.0 g after saline injection (n ¼ 18) and this was unchanged in sham animals that had received GBP injection (15.0 ± 0.0, n ¼ 21).
One in 6 rats that underwent CCI surgery did not develop mechanical allodynia and these rats are called 'non-responders'. As another form of control for comparison to neuropathic rats, we performed experiments on non-responder rats and established that IP GBP did not have a significant effect on PWT compared to saline (Fig. 2a) .
We also confirmed that IP injection of 100 mg/kg GBP rapidly attenuated allodynia (increased PWT) in 12 rats subject to spared nerve injury (SNI, Fig. 2b ). GBP did not affect PWT in sham operated rats (n ¼ 4). This model produces mechanical allodynia which persists for 30 weeks or more (Decosterd and Woolf, 2000) whereas that accompanying CCI abates within 20 weeks (Luo et al., 2001 ).
Gabapentin administration reduces ex vivo dorsal horn excitability in rats subjected to CCI
Rapid antiallodynic actions of GBP in nerve-injured rats in vivo have been associated with a decrease in glutamate release in the spinal dorsal horn (Coderre et al., 2005) . GBP would thus be expected to produce an overall decrease in excitability. To test this, we first examined the overall excitability of spinal cord slices obtained ex vivo from sham operated animals and those subject to CCI. Excitability was assessed by monitoring Ca 2þ influx in response to depolarising 35 mM K þ challenges. In line with previous observations that CCI increases excitatory synaptic transmission and Fig. 2 . Acute anti-allodynic actions of GBP and cellular correlates in the dorsal horn. a. A single intraperitoneal injection of 100 mg/kg GBP significantly increased PWTs within 30 min in neuropathic CCI rats with no effect in non-responder rats that failed to develop allodynia following CCI. For saline injected controls n ¼ 22, for GBP injected n ¼ 23, for non-responders, saline injected n ¼ 6, for non-responders GBP injected n ¼ 6. *One-way ANOVA with Bonferroni correction, p < 0.05. b. Time course of effects of 100 mg/kg on PWT of rats subject to spared nerve injury (SNI). Upward arrows indicate times of single IP injections of drug, PWT was measured 30min after injection PWT in sham operated animals was unchanged (n ¼ 4, grey half filled circles). c. Effect of IP GBP injection on dorsal horn excitability (Ca 2þ response to 35 mM K þ ) in neuropathic CCI versus sham-operated rats.
Prior IP GBP reduces dorsal horn excitability in CCI, but not sham-operated rats. The dorsal horn excitability of CCI rats was higher than sham-operated rats. Controls for sham and CCI rats were injected with IP saline. All experiments were performed blinded to the treatment of each rat until after analysis. CCI GBP, n ¼ 4 rats, 12 slices, 107 cells; CCI (Saline reduces inhibitory synaptic transmission in the spinal dorsal horn (Coull et al., 2003; Balasubramanyan et al., 2006) we found that slices from "neuropathic" animals subject to CCI were more excitable than those from sham operated animals (p < 0.001 Fig. 2c) . In other CCI animals we administered GBP (100 mg/kg IP) prior to euthanasia and the generation of spinal cord slices. This prior injection of GBP attenuated excitability of slices from neuropathic animals (p < 0.001) whereas slices from sham operated animals were Fig. 3 . Neuron Types and Effects of Prior GBP Injection on sEPSC's in Animals Subject to CCI. a, d and g. Sample recordings of AP discharge in delay, tonic and transient neurons in response to two different depolarising current steps. Neuronal RMP was are held at À60 mV prior to current injection. b and c. sEPSC amplitude and inter-event interval (IEI) of putative excitatory delay neurons from CCI rats. n's for GBP-injected ¼ 6 neurons/slices, 6 rats, 753 events. n's for Saline-injected ¼ 7 neurons/slices, 7 rats, 1188 events. p < 0.0001 for both amplitude and IEI). e and f. sEPSC amplitude and inter-event interval of putative inhibitory tonic neurons from CCI rats. n's for GBP-injected ¼ 11 neurons/slices, 10 rats, 636 events. n's for saline-injected ¼ 10 neurons/slices, 7 rats, 397 events. (p > 0.05 for amplitude and p < 0.00005 for IEI). h. and i. sEPSC amplitude and IEI of putative excitatory transient neurons from CCI rats. n's for GBP-injected ¼ 7 neurons/slices, 5 rats, 685 events. n's for saline-injected ¼ 7 neurons/slices, 7 rats, 859 events. For amplitude p < 0.0001 and for IEI p < 0.02. Cumulative probability plots were compared with the Kolmogorov-Smirnov test and statistical significance was attributed if p < 0.05. unaffected (Fig. 2c) . Fig. 2d illustrates superimposed sample recordings of K þ -evoked Ca 2þ responses from 36 neurons in 3 spinal cord slices obtained from an animal that was injected with saline before euthanasia and generation of slices and responses of 34 neurons from another animal that had received 100 mg/kg GBP. The black lines are averages of the illustrated records. Responses from GBP injected animals are smaller than those from saline injected animals.
GBP levels in spinal cord (whole cord and slices) and brain of IP injected animals
Levels of GBP peak in CNS tissues nwithin 1.5 h of intravenous injection or oral administration (Larsen et al., 2016) . We detected 1.89 mg and 1.99 mg of GBP per gram wet weight of spinal cord or brain respectively 45min after IP injection of 100 mg/kg GBP. We also detected 0.55 mg and 0.66 mg of GBP per gram of spinal cord or brain respectively following IP injection of 60 mg/kg GBP. The lack of effect of GBP on paw withdrawal threshold in sham operated animals is unlikely to reflect lack of penetration of the spinal cord and brain by GBP and may rather reflect an absence of effect on neurons from uninjured animals.
Generation of ex vivo spinal cord slices takes approximately 200 min following GBP injection (Fig. 1a) . For part of this time, slices are kept in a dissection solution at 37 C for equilibration. We Fig. 4 . Effects of prior GBP injection on substantia gelatinosa neurons recorded ex vivo from sham operated rats. a. sEPSC amplitude and b. inter-event interval (IEI) of putative excitatory delay neurons from sham-operated rats. n's for GBP-injected ¼ 7 neurons/slices, 5 rats, 99 events. n's for Saline-injected ¼ 5 neurons/slices, 5 rats, 98 events. (p < 0.00001 for amplitude and p > 0.05 for IEI). c. sEPSC amplitude and d. inter-event interval (IEI) of putative inhibitory tonic neurons from sham-operated rats. n's for GBP-injected ¼ 5 neurons/slices, 5 rats, 121 events. n's for Saline-injected ¼ 7 neurons/slices, 5 rats, 315 events. (p > 0.05 for amplitude and p < 0.007 for IEI). e. sEPSC amplitude and f. inter-event interval (IEI) of putative excitatory transient neurons from sham-operated rats. n's for GBP-injected ¼ 4 neurons/slices, 4 rats, 226 events. n's for Saline-injected ¼ 3 neurons/slices, 2 rats, 176 events. (p < 0.0007 for amplitude and p > 0.05 for IEI). Cumulative probability plots were compared with the Kolmogorov-Smirnov test and statistical significance was attributed if p < 0.05. therefore tested whether the depression of dorsal horn excitability seen ex vivo following a prior in vivo injection could be attributed to the continued presence of GBP in the slices. This appeared to be the case as 0.54 ± 0.07 mg/g, GBP was detected in slices from the lumbosacral region of spinal cord neuropathic animals that had received 100 mg/kg GBP (n ¼ 12).
GBP has different effects on inhibitory versus excitatory neurons
The spinal dorsal horn contains a variety of neuronal types which can be classified according to their morphology, neurotransmitter content and electrophysiological properties (Todd, 2010; Stebbing et al., 2016) . To an extent, morphology correlates with firing pattern and neurotransmitter content (Punnakkal et al., 2014; Todd, 2010; Yasaka et al., 2010) . For example, neurons with an islet cell morphology are often GABAergic (Todd and Spike, 1993) and often display a tonic discharge pattern (Grudt and Perl, 2002; Labrakakis et al., 2009) . Neurons with a "delay" firing pattern are often excitatory (Punnakkal et al., 2014) . We have demonstrated that long term (4-5d) exposure of dorsal horn neurons in organotypic culture to gabapentinoids is more effective in inhibiting excitatory synaptic drive to putative excitatory delay firing neurons than to putative inhibitory tonic firing neurons (Biggs et al., 2014) . To determine whether IP GBP has similar, yet rapidly developing, differential effects on input to excitatory versus inhibitory neurons, we examined its ex vivo effects on spontaneous synaptic transmission in tonic neurons and in delay firing neurons. Neurons were classified according to firing pattern using criteria defined in our previous work (Balasubramanyan et al., 2006) . In a sample of 122 neurons, we found 36% tonic, 27% delay, 20.5% transient, 12.5% phasic and 4% irregular firing. Fig. 3a illustrates the typical discharge pattern of a putative excitatory delay neuron. Prior injection of 100 mg/kg GBP reduced average sEPSC amplitude in delay neurons from 26 ± 2.4 pA (n ¼ 7 neurons in 7 slices) to 23 ± 3.3 pA (n ¼ 6 neurons in 6 slices; p < 0.05). The reduction in sEPSCs amplitude in rats that had received GBP and those had received saline is illustrated in a cumulative probability plot (Fig. 3b) where p < 0.001, (K-S test). GBP also reduced average sEPSC frequency (increased interevent interval, IEI) from 905 þ 62 ms (n ¼ 7) to 1435 ± 81 ms (n ¼ 6, p < 0.05). Plotting the data as a cumulative probability plot (Fig. 3c) yielded p < 0.001 (KS statistics). Fig. 3d illustrates the typical discharge pattern of a putative inhibitory tonic neuron. By contrast with its action on delay neurons, GBP did not reduce sEPSC amplitude in tonic neurons (25 ± 8.4 pA, n ¼ 10 in saline injected animals, 25 ± 4.5 pA in GBP injected animals n ¼ 11, p > 0.05). GBP also increased the frequency (decreased the interevent interval) from 4839 ± 456 ms (n ¼ 10) to 3015 ± 205 ms (n ¼ 11, p < < 0.05). Cumulative probability plots for the action of GBP on the amplitude and interevent interval of sEPSCs in tonic neurons are shown in Fig. 3e and f. The decrease in interevent interval is significant (p < 0.001 KS test; Fig. 3f ).
Effects of GBP on sEPSCs in delay neurons
Effects of GBP on sEPSCs in tonic neurons
Effects of GBP on sEPSCs in transient neurons
At least in mice, recent evidence suggests that many transient firing neurons display an excitatory phenotype (Punnakkal et al., 2014) . We therefore examined the effect of GBP injection on their excitatory synaptic drive and found that transient neurons were affected in the same way as putative excitatory delay neurons. Fig. 3g illustrates the typical discharge pattern of a transient neuron; threshold is characteristically high and no more than a single action potential can be generated regardless of intensity of depolarizing current.
Prior injection of 100 mg/kg GBP reduced sEPSC amplitude in transient neurons from animals subject to CCI from 25 ± 2.7 pA (n ¼ 7) to 22 ± 2.8 pA (n ¼ 7) (p < 0.001). The difference between sEPSCs amplitudes in transient neurons from rats that had received GBP and those had received saline is illustrated in a cumulative probability plot (Fig. 3h) where p < 0.001, (K-S test). GBP also reduced average sEPSC frequency (increased interevent interval) from 1522 ± 167 ms (n ¼ 7) to 2220 ± 217 1 ms (n ¼ 7, p < 0.01). Plotting the data as a cumulative probability plot (Fig. 3i) yielded p < 0.02 (KS statistics).
Which actions of GBP are a consequence of nerve injury?
To determine which of the above described actions of GBP are contingent on nerve injury we also examined its actions on sEPSC in delay, tonic and transient neurons from sham operated animals.
In delay neurons, GBP reduced sEPSC amplitude in sham operated animals in a similar fashion to its action on neurons from animals subject to CCI (Figs. 3b and 4a) . By contrast, GBP did not affect interevent interval in neurons from sham operated animals (Fig. 4b) . This differs from its aforementioned action in delay neurons from animals subject to CCI where interevent interval is increased (Fig. 3c) .
GBP did not affect sEPSC amplitude in tonic neurons from sham operated animals and this corresponds with its overall lack of effect on sEPSC amplitude in tonic neurons from animals subject to CCI (Figs. 4c and 3e) . The drug reduced sEPSC frequency (increased interevent interval) in sham operated animals. This contrasted with GBP's aforementioned action on tonic neurons from animals subject to CCI where frequency was increased ( Fig. 4d compared with Fig. 3f) .
In transient neurons, GBP reduced sEPSC amplitude in sham operated neurons in a similar fashion to its action on transient neurons from animals subject to CCI (Figs. 4e and 3h) . By contrast, interevent interval was unchanged in transient neurons from sham operated animals but was increased in neurons from animals subject to CCI (Fig. 4f compared to Fig. 3i) .
From this, we can make the interim conclusion that the effects of GBP to increase interevent interval (reduce sEPSC frequency) in excitatory delay and transient neurons after CCI (Fig. 3c and i) and its ability to decrease interevent interval (increase sEPSC Fig. 5 . Effects of prior GBP injection on the neurotransmitter release process (mEPSC) and intrinsic neuronal excitability of substantia gelatinosa neurons recorded ex vivo from CCI rats. a. mEPSC amplitude and b. inter-event interval (IEI) of putative excitatory delay neurons from CCI rats. n's for GBP-injected ¼ 5 neurons/slices, 4 rats, 281 events. n's for saline-injected ¼ 7 neurons/slices, 4 rats, 580 events. (p < 0.000001 for amplitude and p < 0.002 for IEI). c. Delay neuron mEPSC amplitude data re plotted as frequency histogram (bin width ¼ 5 pA). d. mEPSC amplitude and e. inter-event interval (IEI) of putative inhibitory tonic neurons from CCI rats. n's for GBP-injected ¼ 10 neurons/slices, 7 rats, 322 events. n's for saline-injected ¼ 5 neurons/slices, 3 rats, 172 events. (p < 0.005 for amplitude and p > 0.05 for IEI). f. Tonic neuron mEPSC amplitude data re plotted as frequency histogram (bin width ¼ 5 pA). g-j Measurement of intrinsic neuronal excitability. Depolarising current ramp command bottom and AP firing pattern (top) associated with g. a typical delay firing neurons and h. a typical tonic firing neurons of the substantia gelatinosa. i. cumulative latency to AP discharge is increased (p < 0.005) in putative excitatory delay neurons in GBP compared to saline-injected CCI rats. n's for GBP-injected ¼ 7 neurons/slices, 6 rats. n's for saline-injected ¼ 9 neurons/slices, 7 rats. j. In tonic neurons, cumulative latency for AP discharge is not significantly affected in GBP-compared to saline-injected CCI rats. n's for GBP-injected ¼ 13 neurons/slices, 11 rats. n's for saline-injected ¼ 12 neurons/slices, 11 rats. 133 pAs-1 current ramp was used to plot cumulative latency versus AP spike number in each case. Cumulative latency plots were compared by one-way ANOVA with Bonferroni correction and statistical significance was attributed if p < 0.05. frequency) in inhibitory tonic cells after CCI (Fig. 3f) , are most pertinent to understanding its anti-allodynic actions. Because GBP exerts similar effects on sEPSC amplitude in delay and transient cells from sham operated and animals subject to CCI (Figs. 3b and  4a ; Figs. 3h and 4e), these effects may have little relevance to its antiallodynic action.
Effects of GBP on tonic, delay and transient neurons from sham operated and CCI animals are summarized in Table 1 .
Effects of GBP on mEPSCs
Since GBP decreased sEPSC frequency in delay neurons (Fig. 3c  and i ) and increased it in tonic neurons (Fig. 3f) we determined whether IP GBP had differential effects on the neurotransmitter release process independent of depolarization-induced Ca 2þ influx by examining its effects on mEPSCs.
Effects of GBP on mEPSC's in delay neurons
For delay neurons from animals subject to CCI, the effects of IP GBP on mEPSCs were similar to those on sEPSCs. Average mEPSC amplitude in neurons from saline injected animals was 25.6 ± 0.3 pA (n ¼ 7) and this compared with 18.9 ± 0.3 pA (n ¼ 5) in delay neurons from GBP injected animals (P < 0.001). Average interevent interval was significantly increased (p < 0.01) from 1947 ± 225 ms (n ¼ 7) to 2873 ± 171 ms (n ¼ 5). Similar differences were seen from cumulative probability plots where GBP reduced mEPSC amplitude (p < 0.001), K-S test (Fig. 5a) , and increased interevent interval (p < 0.002, K-S test, Fig. 5b ). To provide further information about the effects of GBP on mEPSC amplitude, we separated events into 5 pA bins and displayed the amplitude data as a frequency histogram (Fig. 5c) . GBP increased the number of small events and decreased the number of small events.
Effects of GBP on mEPSC's in tonic neurons
The effect of GBP on mEPSCs in this population did not at all correspond with its actions on sEPSCs (compare Fig. 5d and e with Fig. 3e and f) . GBP thus increased mEPSC amplitude ( Fig. 5d , P < 0.005 KS test) but had no effect on mEPSC interevent interval (Fig. 5e) . Average mEPSC amplitude in neurons from saline injected animals was 22.8 ± 0.9 pA (n ¼ 5) and this was less than the value of 28.1 ± 1.6 pA (n ¼ 10) in tonic neurons from GBP injected animals (p < 0.02), Interevent interval was not significantly changed (p > 0.05). In tonic neurons from saline injected animals interevent interval was 4808 ± 437 ms (n ¼ 5) compared to 5113 ± 433 ms in neurons from GBP injected animals. Further analysis of the effects of GBP by means of a frequency histogram of binned event amplitudes suggested that the drug increased the amplitude of large events but reduced the amplitude of small events (Fig. 5f ).
Since transient firing neurons were encountered less frequently than tonic or delay firing neurons, the limited number of recordings of mEPSCs we obtained from this population precluded meaningful analysis of the data.
Effects of GBP on intrinsic neuronal properties
To determine whether IP GBP produces differential effects on the intrinsic neuronal properties of putative excitatory delay and putative inhibitory tonic neurons, we studied the cumulative latency of action potentials in response to depolarizing current ramps ( Fig. 5g and h ). GBP injection increased cumulative latency of APs in delay firing neurons in animals subject to CCI (Fig. 5i, p < 0.005) . Although it did not affect cumulative AP latency in tonic neurons (Fig. 5j , p > 0.05, one-way ANOVA), GBP did appear to affect the variance in latency of APs. Note that error bars on data from GBP treated neurons are smaller than controls. It may therefore exhibit some subtle action on spike frequency adaptation in a subpopulation of tonic neurons.
GBP reduces primary somatosensory cortex (S1) excitability in neuropathic rats
It may be argued that the observed actions of GBP on PWT in animals subject to CCI (Fig. 2a and b) and the corresponding changes in synaptic transmission in substantia gelatinosa (Fig. 3-) simply reflect depression of spinal reflexes rather than suppression of pain per se. Therefore, in order to determine whether the acute actions of GBP impact a higher level of somatosensory processing, we examined the effect of IP GBP on excitability of the primary somatosensory cortex (S1).
As an index for overall network excitability in S1, we calculated the 'neural mass' (fraction of responsive neurons a mean dF/F 0 , see Methods) before and 10 min following IP GBP injection. To ensure that Ca 2þ signals were recorded from neurons, we loaded superficial layers of the cortex via bath application of sulforhodamine-101 (SR-101), which is preferentially taken up by glia (astrocytes). By excluding all SR-101-loaded cells, we assumed that the remainder of the Ca 2þ signal was neuronal (Fig. 6a) . Fig. 6b illustrates the averaged response of 114 neurons in S1 to vibrotactile stimulation of the limb that was subject to CCI. As expected, before GBP administration, the neural mass of neuropathic CCI rats was significantly higher than in shamoperated rats (i.e. S1 was hyperexcitable; P < 0.05, one-way ANOVA with Bonferroni correction. Fig. 6c ). Within 10 min of injection, 100 mg/kg IP GBP significantly reduced neural mass in neuropathic CCI rats by approximately 56% (P < 0.05, one-way ANOVA with Bonferroni correction Fig. 6c ). However, neural mass in sham rats was not significantly affected (P > 0.05, one-way ANOVA) 10 min following GBP injection.
Discussion
We confirmed that GBP increases PWT within 30 min of IP injection in CCI and SNI neuropathic rats as has been reported in other pain models (Hunter et al., 1997; Field et al., 2006; Kumar et al., 2013) and in our previous publication (Alles and Smith, 2016) . We now show that this effect in CCI rats correlates temporally with an overall decrease in excitability of dorsal horn and primary somatosensory cortex. Within substantia gelatinosa, effects of GBP correspond to a decrease in excitatory drive to putative excitatory neurons.
From studies in hippocampal neurons, Hoppa et al. (2012) posited that a2d subunits function through two mechanisms. "A trafficking step from the cell soma and a local step at the presynaptic terminal allowing synapses to have increased exocytosis with decreased Ca 2þ influx". We suggest that when a2d1 levels are elevated, either in neuropathic pain models or by genetic modulation (Luo et al., 2002; Luo et al., 2001; Bauer et al., 2009) , it is rapidly and locally trafficked from the endoplasmic reticulum to the plasma membrane of primary afferent nerve terminals. This process is interrupted by gabapentinoids within 30min of intraperitoneal injection and accounts for the rapid actions we observe in ex vivo substantia gelatinosa (Figs. 3e5) . By contrast, in the uninjured situation, the level a2d1 in at neurotransmitter release sites is governed by slower trafficking from the cell bodies to primary afferent terminals (Bauer et al., 2009) . In this situation, a slower action of gabapentinoids represents the gradual depletion of a2d1
at nerve terminals over periods of several days as they do not appear to affect endocytosis (Bauer et al., 2009 ). This may account for the slowly developing effects observed in previous in vitro studies (Biggs et al., 2015; Biggs et al., 2014) .
An intracellular site of in vivo GBP action
Long-term actions of GBP in vitro require its transport into the cytoplasm via the neutral aminoacid transporter (Biggs et al., 2014 : Hendrich et al., 2008 . We suggest that rapidly developing in vivo effects are also mediated via an intracellular action with a2d1. This is because drug actions in substantia gelatinosa persist ex-vivo (Figs. 3e5) and GBP can be detected in spinal cord slices after their removal from animals that were displaying an anti-allodynic response to the drug. GBP is not particularly lipophilic, so it is unlikely that its persistence in the tissue reflects non-specific binding to cell membranes. The K D for GBP binding to a2dÀ1 is in the 100 nM range Lana et al., 2016) . Assuming a diffusion-limited association rate constant of 10 6 to 10 8 per molar per second, the average bound time for a single molecule of GBP would lie between 1 and 100 s. Since the slices are washed in a relatively large volume of aCSF (~200 ml) for 60 min or more, it is very unlikely GBP remains bound to an extracellular site on a2dÀ1
and more probable that intracellular retention accounts for our observations These observations are congruent with those of Lana et al. (2016) who showed that GBP displacement of thrombospondin 4 binding is effected at an intracellular site on a2dÀ1.
GBP has differential actions on excitatory compared to inhibitory neurons
In general, GBP decreases excitatory drive to putative excitatory neurons but has weaker and more complex actions on excitatory drive to putative inhibitory neurons (Table 1 ). This fits with the observation that its rapid actions are associated with an overall decrease in excitability of spinal cord slices from nerve injured animals ( Fig. 2c and d) . It is also consistent with the finding that glutamate release is decreased in vivo in nerve injured animals (Coderre et al., 2005) and that GBP has little effect on GABA/glycine mediated mIPSCs in deep dorsal horn (Zhou and Luo, 2015) . Our analysis of ex vivo GBP actions were confined to effect on spontaneous synaptic activity as the amplitudes of EPSCs evoked by dorsal root stimulation are highly variable (Lu and Perl, 2005; Biggs et al., 2014) and this precludes statistical comparison of GBP effectiveness from sham operated and CCI animals. Although this means we cannot distinguish between synaptic activity from primary afferents and that from other excitatory interneurons this may have little bearing on the ability of GBP to damp down overall dorsal horn excitability.
Effects of GBP on putative excitatory delay and transient neurons
We have defined excitatory neurons on the basis of the initial delay in action potential discharge by depolarizing current pulses (Fig. 3a) . It should be noted that in a detailed morphological and electrophysiological study of lamina II neurons, the delayed firing pattern was only ever seen in excitatory neurons that were identified by the presence of VGLUT2 (vesicular glutamate transporter 2) immunoreactivity (Yasaka et al., 2010) . GBP reduced the amplitude of sEPSCs in putative excitatory delay neurons from animals subject to CCI (Fig. 3b) . It is not known whether this action is a2d-1-dependent as it was also seen in sham operated animals ( Fig. 4a ; Table 1 ). Decreased sEPSC amplitude may be a consequence of decreased mEPSC amplitude (Fig. 5a) . Because GBP increased the number of small mEPSC events while decreasing the number of large events (Fig. 5c ) this suggests the drug acts presynaptically to reduce quantal size or quantal content or both. The GBP-induced increase in IEI (decrease in frequency) of sEPSCs in delay neurons (Fig. 3c) is not seen in sham operated animals (Fig. 4b) , but corresponds to a decrease in mEPSC frequency (Fig. 5b ) and presumably to a presynaptic site of action that appears only in neuropathic animals.
Although we do not have mEPSC data for GBP actions on In vivo primary somatosensory cortical imaging in neuropathic CCI rats immediately following IP GBP. 100 mg/kg intraperitoneal GBP injection reduced cortical excitability (neural mass) in neuropathic CCI (n ¼ 3 rats) within 10 min of injection, with no significant reduction observed in sham-operated rats (n ¼ 2 rats). A reduction in cortical excitability was observed in sham-operated rats at 20 min post-injection with no further reduction observed in neuropathic rats compared to 10 min post-injection. At 30 min post-injection there were no significant differences compared to at 20 min post-injection in cortical excitability of either CCI or sham-operated rats. *p < 0.05, one-way ANOVA with Bonferroni correction. All data are presented as mean ± SEM. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) putative excitatory transient neurons, effects on sEPSC's exactly parallel those seen in delay neurons (Table 1 ). The amplitude of sEPSC's is thus reduced in both sham operated animals and those subject to CCI (Figs. 3h and 4e ). Interevent interval is only increased in animals subject to CCI (Fig. 3i) and not in shams (Fig. 4f) . Taken together, the data from transient and delay neurons suggest that a presynaptic action to attenuate release of glutamate onto putative excitatory neurons may play a major role in GBPinduced decrease in dorsal horn excitability in neuropathic animals as suggested by Coderre et al. (2005) . Yasaka et al. (2010) identified 23 inhibitory neurons in rat lamina II by the presence of immunoreactivity for the vesicular GABA transporter (VGAT). All but 2 of these cells exhibited a tonic firing pattern. We therefore used the presence of a tonic firing pattern to identify inhibitory neurons. GBP slightly increased the amplitude of mEPSCs in putative inhibitory tonic neurons in CCI animals ( Fig. 5d ). This is unlikely to reflect a postsynaptic effect as sEPSC amplitude was unchanged ( Fig. 3e; Fig. 4c ; Table 1 ). It may rather reflect a presynaptic action such that the amplitude of large events is increased whereas that of small events is decreased (Fig. 5c) . Regardless of the mechanism, an increase in mEPSC amplitude that is not reflected as a change sEPSC amplitude is unlikely to contribute to the overall depressant and antiallodynic actions of GBP.
Effects of GBP on putative inhibitory tonic neurons
GBP decreased the frequency (increased the interevent interval) of sEPSC in tonic neurons from sham operated animals (Fig. 4d) , did not affect mEPSC frequency in CCI animals ( Fig. 5e ) yet did increase sEPSC frequency (Fig. 3f) . Since tonic firing cells are usually inhibitory (Yasaka et al., 2010) , this latter effect is consistent with an overall decrease in substantia gelatinosa excitability ( Fig. 2c and d) . The underlying mechanism is however difficult to explain.
GBP's effect on intrinsic neuronal excitability of substantia gelatinosa neurons
The ex vivo data presented in Fig. 5i and j suggest that IP GBP has a differential but rather weak effects on the excitability of delay and tonic neurons. In the first case, latency to action potential discharge is increased. This suggests that delay neurons, which are mostly excitatory (Punnakkal et al., 2014; Yasaka et al., 2010) will require a longer depolarizing stimulus to generate an action potentials after GBP injection. In tonic, putative inhibitory neurons, GBP reduces the cell to cell variability in cumulative latency of AP generation. It remains to be determined whether these actions contribute to the overall decrease in excitability seen with GBP ( Fig. 2c and d ).
GBP and nociceptive processing at the level of the somatosensory cortex
We can never really know to what extent the effects of GBP in animals models represent the antiallodynic and pain-suppressing effects observed in the clinical situation. Recent evidence suggests that gabapentinoids may be effective in operant models which require cortical processing of noxious stimulation (Harte et al., 2016) . The emotional experience of pain involves a complex system of neural structures in the brainstem reticular formation and the limbic system One such neural structure involved in affective pain processing involves the anterior cingulate cortex (ACC) (Chen et al., 2014b; Zhuo, 2008; Chen et al., 2014a) . Unfortunately, for our studies these structures are too deep (>500 mm) to easily image using two-photon laser scanning microscopy. However, imaging in layer II/III of S1 showed that IP gabapentin rapidly depressed the activity generated by a vibrotactile stimulus (Fig. 6 ). This suggests that somatosensory activation resulting from processing of peripherally generated cutaneous and proprioceptive information is elevated in untreated animals after CCI, thereby leading to hyperexcitability of S1, and that this hyperexcitability is reversed by GBP. This may relate to the drugs anti-allodynic action.
Since GBP exerts inhibitory actions on synaptic transmission in anterior cingulate cortex (Chen et al., 2014b) , it remains to be determined whether the effects of GBP seen in S1 cortex in vivo (Fig. 6 ) reflect a direct action on cortical networks, and/or whether they are an "upstream" consequence of inhibition at the spinal and/ or thalamic level. In support of effects of gabapentinoids on pain processing in subcortical structures, it has recently been shown that pregabalin, exerts actions on sensory processing in the ventral posterior thalamus of neuropathic animals (Patel and Dickenson, 2016) .
Our data are consistent with the idea that levels of a2d protein dictate the rapidity of gabapentinoid action (Alles and Smith, 2016) , and this involves an intracellular action to reduce glutamate release from excitatory terminals onto excitatory neurons. In addition, they provide a hypothesis for understanding the slow rate of onset of gabapentinoid effect in the clinic where drug effects take several days to develop (Sharma et al., 2010) . In a spinal nerve ligation model of neuropathic pain, a2d1 levels are elevated at 2e4 weeks but return to pre-injury levels with time (Luo et al., 2001) . If a similar situation occurs in patients and a2d1 levels decrease with time despite the chronic persistence of neuropathic pain, a slowly developing action of GBP may be predicted (Alles and Smith, 2016) .
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